How much drug in the tablet?

@article{Venning1991HowMD,
  title={How much drug in the tablet?},
  author={Geoffrey R Venning and David B. Jack and Caroline Tung Richmond},
  journal={The Lancet},
  year={1991},
  volume={337}
}

Social aspects in additive manufacturing of pharmaceutical products

This work summarizes the concept of personalized medicine and gives an overview of possibilities for monitoring patients’ health, as well as whether AM will be used for production of on-demand medicine.

Clinical Trials: – Collection of Safety Data and Establishing the Adverse Drug Reaction Profile

All clinical trials should have a safety component as a primary or secondary objective, but safety and tolerability must also be included as a secondary objective.

References

SHOWING 1-2 OF 2 REFERENCES

Rare and Serious Adverse Reactions

  • G. Venning
  • Medicine
    Medical toxicology and adverse drug experience
  • 1987
There have been a number of classifications of adverse drug reactions, but perhaps the most useful has been that proposed by Rawlins and Thompson (1977). They described two types of reactions. Type A

Relation between dose of bendrofluazide, antihypertensive effect, and adverse biochemical effects.

The relevant range of doses of bendrofluazide to treat mild to moderate hypertension is 1.25-2.5 mg a day, and clear relations between dose and effect were shown for potassium, urate, glucose, total cholesterol, and apolipoprotein B concentrations.